Andrew Zambanini, M.D.
Andrew Zambanini, M.D.

Translational Medicine Advisor

Atopix Therapeutics, Chief Medical Officer

Clinical Development Consultant to Annapurna Therapeutics, Adverum Biotechnologies, Circassia, Theracos, Ferrumax, Kyowa Hakko Kirin, GSK, and Novartis

Vice-President and Medicine Development Leader (diabetes, immunoinflammation), GSK

Cardiovascular Clinical Head (Europe), GSK

Research Fellow in Clinical Pharmacology, Imperial College, London, UK

Research Fellow in Cardiology, Green Lane Hospital, Auckland, New Zealand

Licensed UK physician (St. George’s Hospital Medical School)

Dual board certified UK specialist in Clinical Pharmacology and Pharmaceutical Medicine

Member of the Royal College of Physicians of London

Fellow of the Faculty of Pharmaceutical Medicine, London

Valentina Brambilla
Valentina Brambilla

Clinical Trial Assistant

Marie-Curie PhD (to be submitted), University of Exeter Medical School, UK

Clinical Research Training Course (2018), Missione CRA – YGHEA, Milan, Italy

Fellowship & Internship during the Master’s degree (2011-2013), San Raffaele Scientific Institute, Milan, Italy

Master’s degree in Drug Biotechnology (2012), University of Milan, Italy